Iovance Biotherapeutics
IOVA
#5204
Rank
NZ$1.92 B
Marketcap
$5.89
Share price
4.46%
Change (1 day)
-69.61%
Change (1 year)

Earnings for Iovance Biotherapeutics (IOVA)

Earnings in 2024 (TTM): -NZ$0.66 Billion

According to Iovance Biotherapeutics 's latest financial reports the company's current earnings are NZ$0.16 Billion. , an increase over its 2023 earnings that were of -NZ$0.78 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Iovance Biotherapeutics from 2008 to 2024

Annual earnings

Year Earnings Change
2024 -NZ$0.67 Billion-14.17%
2023 -NZ$0.78 Billion15.46%
2022 -NZ$0.67 Billion16.39%
2021 -NZ$0.58 Billion30.83%
2020 -NZ$0.44 Billion26.62%
2019 -NZ$0.35 Billion61.29%
2018 -NZ$0.22 Billion38.09%
2017 -NZ$0.16 Billion73.16%
2016 -NZ$89.95 Million92.7%
2015 -NZ$46.68 Million131.17%
2014 -NZ$20.2 Million-51.71%
2013 -NZ$41.82 Million6291.81%
2012 -NZ$0.66 Million
2008 -NZ$0.1 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$59.16 M-108.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$3.63 Million-99.45% Bahamas